Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 221.35 INR
Change Today +4.55 / 2.10%
Volume 164.0K
JBCP On Other Exchanges
Symbol
Exchange
Natl India
As of 6:18 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

j.b. chemicals & pharma ltd (JBCP) Snapshot

Open
216.00
Previous Close
216.80
Day High
225.00
Day Low
215.30
52 Week High
04/15/15 - 268.50
52 Week Low
05/19/14 - 136.10
Market Cap
18.8B
Average Volume 10 Days
295.8K
EPS TTM
7.26
Shares Outstanding
84.8M
EX-Date
09/4/14
P/E TM
30.5x
Dividend
3.00
Dividend Yield
1.36%
Current Stock Chart for J.B. CHEMICALS & PHARMA LTD (JBCP)

Related News

No related news articles were found.

j.b. chemicals & pharma ltd (JBCP) Related Businessweek News

No Related Businessweek News Found

j.b. chemicals & pharma ltd (JBCP) Details

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and APIs in India. The company offers generic products and formulations in the form of tablets, capsules, creams and ointments, injectables, liquid herbal syrups, and lozenges. It also manufactures iodinated contrast media, which are radiopaque substances used to study internal structures of the body in X-ray procedures, such as computed tomography and cardiac catheterization. In addition, the company’s APIs include atenolol USP, cilnidipine, diclofenac acid, and diclofenac diethylamine BP/EP. Further, it provides contract manufacturing services to pharmaceutical companies. The company also exports its products primarily to Russia, Ukraine, CIS countries, and South Africa. J. B. Chemicals & Pharmaceuticals Limited was founded in 1976 and is headquartered in Mumbai, India.

Founded in 1976

j.b. chemicals & pharma ltd (JBCP) Top Compensated Officers

Chairman, Managing Director and Member of Sha...
Total Annual Compensation: 16.0M
President, Director of Operations and Whole-T...
Total Annual Compensation: 7.7M
Director of Technical & Production and Execut...
Total Annual Compensation: 4.4M
Director of Administration, Whole-Time Direct...
Total Annual Compensation: 16.0M
Director of Planning & Development and Whole-...
Total Annual Compensation: 7.7M
Compensation as of Fiscal Year 2014.

j.b. chemicals & pharma ltd (JBCP) Key Developments

J. B. Chemicals & Pharmaceuticals Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

J. B. Chemicals & Pharmaceuticals Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported total income of INR 2,654.3 million against INR 2,603.6 million for the same period previous year. Profit from operations before other income and finance costs but before exchange fluctuation translation gain was INR 375.5 million against INR 558.6 million for the same period of previous year. Profit before tax was INR 351.4 million against INR 12.8 million for the same period of previous year. Profit after tax was INR 241.7 million or INR 2.85 earnings per share compared to loss after tax of INR 64.7 million or INR 0.76 loss per share for the same period of previous year. Profit from operations before finance cost and depreciation at INR 485.5 million was 13% higher against the same quarter in the pervious year. For the nine months, the company reported total income of INR 8,063.289 million against INR 7,279.361 million for the same period previous year. Profit from operations before other income and finance costs but before exchange fluctuation translation gain was INR 1,244.489 million against INR 1,113.300 million for the same period of previous year. Profit before tax was INR 1,203.781 million against INR 1,335.338 million same period of previous year. Profit after tax was INR 1,203.781 million or INR 10.36 earnings per share compared to INR 469.936 million or INR 5.55 per share for the same period of previous year.

J. B. Chemicals & Pharmaceuticals Ltd. to Report Q3, 2015 Results on Feb 04, 2015

J. B. Chemicals & Pharmaceuticals Ltd. announced that they will report Q3, 2015 results on Feb 04, 2015

J. B. Chemicals & Pharmaceuticals Ltd., Board Meeting, Feb 04, 2015

J. B. Chemicals & Pharmaceuticals Ltd., Board Meeting, Feb 04, 2015. Agenda: To consider and approve unaudited financial results for the quarter ending on December 31, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JBCP:IN 221.35 INR +4.55

JBCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JBCP.
View Industry Companies
 

Industry Analysis

JBCP

Industry Average

Valuation JBCP Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact J.B. CHEMICALS & PHARMA LTD, please visit www.jbcpl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.